Japan Approves Dermavant’s Tapinarof Cream in PsO and AD
Japan has approved tapinarof cream, 1% (Vtama, Dermavant) for the treatment of adults with psoriasis and patients 12 years of age and older with atopic dermatitis. VTAMA cream, 1% is a novel, aryl hydrocarbon receptor agonist in development in the U.S. as a once-daily, cosmetically elegant, and steroid-free, topical cream for both acute treatment and […]